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Abstract
In recent years long-read technologies have moved from being a niche and specialist field to a point of relative maturity likely to
feature frequently in the genomic landscape. Analogous to next generation sequencing, the cost of sequencing using long-read
technologies has materially dropped whilst the instrument throughput continues to increase. Together these changes present
the prospect of sequencing large numbers of individuals with the aim of fully characterizing genomes at high resolution. In this
article, we will endeavour to present an introduction to long-read technologies showing: what long reads are; how they are dis-
tinct from short reads; why long reads are useful and how they are being used. We will highlight the recent developments in this
field, and the applications and potential of these technologies in medical research, and clinical diagnostics and therapeutics.
When Short Reads Are Not Enough
DNA is an extraordinarily compact storage medium, so small
that developing ways to decode the sequence encoded in these
molecules has been a topic of research for many years. The first
method developed for sequencing DNA, often known as Sanger
sequencing (1), was a low throughput process that detected
bases by incorporation into a template strand, sequencing frag-
ments of DNA up to 1000 bp long. The breakthrough allowing
sequencing at scale finally came with the advent of next genera-
tion sequencing (NGS) technology, which employed massively
parallel reactions for high throughput. While these technologies
have been able to capture sequence from the majority of the ge-
nome and have found utility in the study of disease, their short
reads and lack of contextual information has limited their util-
ity in genome assembly and in resolving complex and repetitive
regions of the genome.
The incremental improvements in read-length that this gen-
eration of technology can yield is one of diminishing returns.
Thus, to achieve substantial gains in mapping, assembly and
phasing one must consider technology that provides an order of
magnitude increase in read-length (2). Practically also, there are
many important problems in genetics where a short read of
DNA (<1000 base pairs) is insufficient (Table 1 and Fig. 1).
Key to achieving high quality results with all long-read tech-
nologies is the use of high molecular weight DNA as a starting
material. The utility of these methods depends on a long DNA
fragment size, with DNA damage and fragmentation limiting
the quality of data obtained. Specific protocols for DNA extrac-
tion such as the agarose gel protocol for BioNano are ideal to
maximize yield from these methods.
Long-Read Technologies
Single molecule real time sequencing
The first long-read sequencing technology to achieve a wide-
spread deployment is the single molecule real time (SMRT)
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sequencing technology from Pacific Biosciences (PacBio). The
SMRT system implemented in their Sequel and RS- II platforms
uses a massively parallel system of polymerases each bound to
a single molecule of target DNA that has been circularized with
a pair of hairpin sequencing adaptors (the SMRTbell) (Fig. 2A).
Incorporation of labelled bases by a polymerase on the template
strand causes fluorescence. The resulting signal is detected by a
CCD camera via a zero-mode waveguide (6,7), yielding a combi-
nation of signal and time series information. Reads produced by
this technology typically peak at 100 Kbp in length and a typical
N50 on recent polymerases is 20 Kbp.
One complication of SMRT sequencing is the high error rate
of this process relative to short read sequencing, at 11–14%
depending on polymerase and chemistry. However, this error
mode is stochastic (by contrast with other technologies), and
can be mitigated by repeated measurements of the sequence.
With PacBio sequencing, this is carried out by repeated forward
and reverse sequencing passes over the circularized SMRTbell
molecule (Fig. 2A). Adaptor sequences can be removed from the
generated sequence to provide enough subreads to generate a
highly accurate consensus of each molecule. This process is
known as circular consensus sequencing and has been shown
to reduce basecalling error substantially (8) whilst also enabling
the strand specific calling of base modifications in unamplified
DNA (9). When long DNA fragments are sequenced, these may
not be parsed more than once in the SMRTbell; in this case, in-
creasing coverage and then calling a consensus across reads
can also achieve a reduced error rate; a method frequently used
in polishing assemblies (10).
Oxford Nanopore Technologies
The next successful single molecule technology to hit the mar-
ket was that produced by Oxford Nanopore Technologies (ONT)
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Figure 1. Behaviour of reads around genomic events. (A) Large insertion: short reads at the edge of the variant are be soft-clipped. Reads within the insertion will be ei-
ther unmapped or mapped incorrectly. Large reads will either span the insertion or have enough context to be marked as inserted sequence. (B) Large deletion: short
reads spanning the deletion may be mismapped or only have one of the reads marked as mapped because the reference measured length indicates the insert size devi-
ates from the expected distribution. Long reads will span the gap but most will have enough context to call the deletion. (C) Copy number variation: where the read-
length exceeds the length of the CNV region reads will map correctly. Shorter reads may be collapsed and show up as increased depth in a pileup or be marked as map-
ping poorly. (D) Inversion: reads will either be represented as a primary alignment with an inverted supplementary or manifest as soft clipping around the edge of the
inversion with a reduction in depth where reads span the edge of the inversion.
Table 1. Advantages and applications of long-read sequencing
Limitations of short read data Applications and advantages of long-read sequencing
• Access to high GC content regions
• Resolution of complex regions of the genome (e.g. MHCa)
• Repetitive regions where short reads will not map uniquely
• Systematic context-specific error modes
• Structural variation, and large segmental duplications
• Paralogous regions of the genome
• Resolution of phase (read-based phasing)
• De novo assembly from long reads to span the low complexity and re-
petitive regions, to create accurate assemblies (3).
• Targeted sequencing of complex genomic and paralogous regions
and resolution of phase for clinical applications e.g. HLAb typing,
ADPKDc (4).
• Transcriptomics, allowing full length sequencing of isoforms and ex-
amination of splicing (5).
• Detection of structural variants (e.g. segmental duplications, gene loss
and fusion events)
• Single molecule sequencing allows examination of clonal heterogeneity
of pathogens, and immunogenic cells
• Long-range characterization of methylation patterns
aMHC: Major histocompatibility complex.
bHLA: Histocompatibility leucocyte antigen.
cADPKD: Autosomal-dominant polycystic kidney disease.
R235Human Molecular Genetics, 2018, Vol. 27, No. R2 |
(11). This technology is based on passing a single strand of DNA
through a nanopore with an enzyme attached, and measuring
changes in the electrical signal across the pore (Fig. 2B). The sig-
nal is then amplified and measured to determine the bases that
passed through. As the pore holds several bases at a time (typi-
cally 5-mers), overlapping k-mers that cause changes in raw
current must be inferred and used to make base calls, a process
which can be error prone. By measuring the shape of the mole-
cule passing through the pore ONT not only reads the sequence
of the DNA but like SMRT is also able to detect base modifica-
tions (12). However, unmodelled base modifications and sys-
tematic DNA context-specific errors (13) currently limit the
utility of the technology.
Oxford Nanopore MinION technology heralds the promise of a
pocket size sequencer, with reads from ONT that can stretch into
the hundreds of kilobases with appropriate DNA preparation, and
megabase long reads that have been observed when a large num-
ber of flow cells have been used. There appears to be no intrinsic
read-length limit for ONT, other than the size of DNA fragments.
Recent improvements in technology, library preparation and
throughput have allowed the first human line sequenced on the
MinION (GM12878) earlier this year (14). This study generated
ultra-long reads (>800 Kbp), and suggested that addition of mod-
est coverage with ultra-long-read sequencing to existing assem-
blies may substantially improve resolution of contigs and
haplotypes. While the error rate is comparable to SMRT sequenc-
ing, a component of the error is systematic and context-specific,
limiting the ability to correct this by increasing coverage (13) and
requiring polishing with other technologies instead.
ONT has developed a distinct strategy to mitigate stochastic
error on their platform, focusing on the way that the template
strand passes through the pore. ONT cannot simply circularize
the DNA. Instead, both the template and complement strands of
the DNA molecule are joined by a hairpin loop during library prep
(2D) or tethered in such a way (1D2) to allow sequential forward
and reverse strand sequencing. Combining these data greatly
enhances accuracy and reduces random error.
The use of nanopores as a nucleic acid sequencing technol-
ogy is not entirely exclusive to ONT; at least one similar but dis-
tinct competing technology is also under development by
Roche.
10X Genomics Chromium system
An alternative to the aforementioned single molecule sequenc-
ing methods is the 10X Genomics Chromium system. Whilst
this is not technically a long-read sequencing technology, it is
an important member of this ecosystem and can solve similar
problems such as mapping, phasing and assembly (Fig. 2C).
Chromium has lower cost compared to ONT and SMRT because
of the use of the nearly ubiquitous Illumina short reads in its se-
quencing process.
The basis of this technology (15) is the barcoding of large
fragments of DNA (preferably>100 Kbp) in an initial digital
droplet polymerase chain reaction (PCR) step. In each droplet, a
single fragment is both sheared and then tagged with a semi-
unique molecular barcode (Fig. 2C). The resulting fragments are
then sequenced like any other Illumina library. The barcode
allows for determination of the relative spatial orientation of
the tags, and allows phasing and assembly of contigs by com-
bining information across multiple tags (15,16). Additionally, be-
cause the data provide spatial orientation across the genome, it
is possible to use it to scaffold data from other methods (17).
Allied technologies
Allied technologies associated with long-read sequencing such
as: optical mapping, HiC and similar have been used to enhance
the final results from sequencing. Optical mapping technologies
such as BioNano Irys and Saphyr label DNA and then image the
labelled DNA to generate genome maps. These genome maps
are used to scaffold contigs produced by assembly (18) and also
to discover large (>500 bp) structural variants and inversions.
HiC can be used to assay chromosomal conformation and is
particularly useful in assigning assembled sequences to chro-
mosomes (19).
The Utility of Long-Read Technology: Recent
Developments
High resolution genome assemblies
Accurate assemblies of the genomes of organisms are crucial to
understanding organismal diversity, speciation, evolution of
species and the impact of genomic diversity on health and dis-
ease. The current human genome reference GRCh38 has been
assembled from the DNA of multiple donors, and represents a
mosaic of haplotypes. However, several studies have suggested
that existing human reference genomes may not fully reflect
the diversity of global human populations, and may be biased
towards diversity in European populations (20–22). This has im-
portant implications for human basic and medical research.
Assembling the human genome has involved extensive cura-
tion with clone-based assembly methods and Sanger sequenc-
ing. Long-read technologies provide a high throughput platform
for characterization of genomes through highly contiguous as-
semblies (Fig. 3).
The early long-read platforms produced reads that were
only a few kilobases long with a high per-base cost; however,
they quickly carved a niche in the creation and finishing of as-
semblies. These long reads could close gaps in genomes by
spanning the low complexity regions that would otherwise re-
quire many costly YAC, BAC and fosmid clones to be created
and sequenced. Thus, many of the early tools such as PBJelly
were focused on gap closure (23,24). The high per-base error
rate also required new assembly algorithms, and new tools
were created to polish the final assembly with Illumina reads to
eliminate basecalling error (12). Clone based assembly methods
were not eliminated entirely either as they provided useful spa-
tial context, but long reads provided a new way to sequence
clones in a high throughput manner (25).
Long-read sequencing methods have contributed to platinum
quality reference sequences such as NA12878 (14,26) and the hap-
loid sequences CHM1 (27) and CHM13 (28), as well filling many
gaps in the human reference (18,25,29). Of particular note are the
first Chinese (18) and Korean (25) human reference genomes
which have been created to answer questions about population-
specific sequence. These sequences have resulted in highly
contiguous assemblies, closing a high proportion of gaps in the
human genome. These have led to discovery of population-spe-
cific sequences, demonstrating the need for further assemblies
from non-European population groups. Recently, higher coverage
sequencing (60) of two haploid genomes has also been used to
identify substantial structural variation, the vast majority of
which have not been recovered from sequencing using NGS tech-
nologies (28). Characterization of high resolution population-spe-
cific reference genomes from initiatives such as the Genome in a
Bottle (GIAB) (30) and the Genome Diversity in Africa project
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Figure 2. Long-read sequencing technologies. (A) PacBio SMRT sequencing. Double stranded DNA is first sheared and size selected to the desired length and then se-
quencing adaptors are annealed. The adaptors are bound to a sequencing primer and strand displacing polymerase which adheres to the bottom of a well containing a
zero mode wave guide. Following a pre-extension period where the polymerase reaction is run in the dark, the fragment is illuminated with a laser and as each base in
the sequencing solution is incorporated, the fluorophore is detected and the polymerase reaction displaces it, giving a time and intensity signal which is converted
into a base call. (B) Oxford Nanopore Technology passes the DNA molecule through a nanopore attached the flow cell surface membrane. As each base of the DNA mol-
ecule passes through the pore changes to the current passing through the pore are detected and converted into a signal. The signal detected is passed to a recurrent
neural network (RNN) which converts it into base calls. (C) 10X Genomics Chromium technology works by means of an emulsion droplet technology, where gel beads
are mixed with high molecular weight genomic DNA and an enzyme. Within each gel bead DNA is sheared and barcoded, creating fragments which can then be se-
quenced with Illumina sequencing. The presence of the chromium barcode then provides a mapper or assembler with linked-reads, allowing the relative spatial posi-
tion of the fragments to be estimated Components of figure reproduced with permission from Pacific Biosciences, Oxford Nanopore Technologies and 10X Genomics.
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(GDAP) (31) (Fig. 3) will provide important resources for popula-
tion and medical genetics, and also allow a clearer understanding
of the evolutionary demographic history of different populations
by better delineation of phase (31).
Most human assemblies have involved a haploid representa-
tion of the genome, where information from the two chromo-
somes is collapsed into a single sequence. Generation of
haplotype representations of the genome can reduce error in
the final assembly, particularly in the case of segmental dupli-
cations (16,32). While long-read technologies can generate
phase information over long contiguous segments, these meth-
ods cannot resolve phase over long regions of homozygosity or
assembly gaps. Assembly of haploid genomes, therefore,
requires additional contextual information, which can be pro-
vided by linked-read approaches. More recently, trio based
methods (where parents are sequenced using Illumina short
reads, with offspring sequenced with long reads) have been
used to provide this contextual information by separation of
maternal and paternal haplotypes prior to assembly using a fa-
ther–mother–offspring trio (33). This method has been applied
to yield a highly contiguous diploid assembly of an F1 hybrid of
two bovine subspecies with a quality surpassing previous cattle
reference genomes (33).
Long reads have been successfully applied to organisms with
smaller genomes as well as bacteria and viruses, with the advan-
tage that for some of these the entire genome can be spanned by
a single long read (34). The Tree of Life initiative, a collaboration
across multiple centres is in the process of developing high reso-
lution reference sequences for>50 vertebrate species using a
combination of long read, short read and linked-read approaches.
Another leading project is the large bacterial sequencing project
NCTC 3000 at the Wellcome Sanger Institute, which is using
PacBio sequencing to sequence complete bacterial genomes
(https://www.phe-culturecollections.org.uk/collections/nctc-3000-
project.aspx). These relatively small genomes (Escherichia coli is
for example 4.6 Mbases) can often have their chromosomes and
plasmids assembled into single contigs. The construction of full
and accurate assemblies of these organisms allow fine-scale phy-
logenies of these organisms to be constructed and is also helpful
in the field of epidemiology when tracing the source of an out-
break. A recent example of this was a study where SMRT se-
quencing was used to identify a reservoir of antibiotic resistant
plasmids within hospitals (35).
In addition to DNA sequencing, ONT sequencing has been
applied to sequence RNA directly rather than relying on an in-
termediate cDNA step, allowing direct sequencing of RNA vi-
ruses and detection of splice variants and base modifications
directly from RNA molecules. An example of this is the recent
direct sequencing and assembly of the influenza A virus in a na-
tive RNA form without amplification or conversion to DNA (36).
Targeted sequencing
From a clinical point of view targeted sequencing is an area
where long reads are likely to have the greatest initial impact.
In the diverse, complex and clinically relevant regions such as
the histocompatibility leucocyte antigen (HLA) (37), killer cell
immunoglobulin-like receptor (KIR) (38) and BRCA; and in phar-
macologically relevant genes such as CYP2D6 (39,40), targeted
sequencing has allowed clinicians and researchers to character-
ize areas of the genome which were previously inaccessible us-
ing NGS methods. In addition, where diversity is high it has
become possible to call and phase variation across the entire
gene. This approach has since been used to retype 126 HLA ref-
erence samples across 6 loci and is now considered a gold stan-
dard for clinical sequencing for stem cell transplants (41).
Typically, when targeting such a region, a long-range PCR reac-
tion is used to specifically amplify the genes of interest. However
Figure 3. Long reads span and call variations that short reads cannot. IGV (http://software.broadinstitute.org/software/igv/home) image of (top) PacBio reads from a
sample sequenced as part of the GDAP project. The reads span a 6 kb heterozygous LINE-1 element deletion and show clear depth variation. Illumina (bottom) reads
from the same sample unable to be clearly mapped around the deletion with reads in white indicating where reads were unable to be uniquely mapped.
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recently there have been studies demonstrating the use of pull-
downs and CRISPR-CAS9 to capture the region of interest with lit-
tle or no amplification (42). The advantage of these reduced and
non-amplification based approaches is the removal of PCR error
as a factor, particularly in tandem repeats and GC rich regions
(42). Additionally, in the case of CRISPR methods, capture of raw
genomic material allows DNA modification information to be
read.
Transcriptomics and RNA
In addition to its many uses with DNA, long-read technology
also has provided many new insights into the world of tran-
scriptomes and ncRNA by allowing for sequencing of these full
length isoforms rather than relying on the assembly of sheared
NGS fragments, a method prone to a high rate of false positives
and ambiguities (43). Direct sequencing of isoforms can be par-
ticularly useful in complex polyploid genomes such as the cof-
fee plant (44), where construction of a reference transcriptome
is otherwise extremely challenging. In addition to its usefulness
in reference transcriptomes IsoSeq has been used in functional
studies to analyse the expression of various disease-linked pro-
teins such as TP53 in leukaemia (45).
The MinION platform has recently been used to sequence
cDNA; applications of this, such as single cell sequencing of im-
mune cells illustrates the power of such methods to examine
clonal heterogeneity in gene expression and isoform usage, po-
tentially revolutionizing our understanding of the repertoire
and functions of immunological cell receptors (46).
Epigenetics
SMRT sequencing technology is able to detect base modifica-
tion, as it records base kinetics of the polymerase, when DNA
molecules are sequenced directly without PCR. Similarly,
Nanopore technology can also detect base modifications due to
variation in ionic currents. However, because amplification of
DNA would erase base modifications, these methods require
relatively large amounts of native, unamplified DNA as input
material. Recent innovations that combine bi-sulphate conver-
sion with SMRT sequencing have allowed direct high through-
put analysis of CpG methylation without requiring large
quantities of sample (47), providing an avenue for more accu-
rate assessment of CpG islands, and allele-specific CpG
methylation.
Clinical applications
The advantages of long-read technologies in accessing complex
regions of the genome, make these ideal for clinical applications
in diagnosis, prognostication and personalized medicine. Early
clinical applications have included sequencing of tandem
repeats in fragile X syndrome, spinocerebellar ataxia, providing
accurate diagnostics and potential for prognostication in clini-
cal genetics. SMRT sequencing has also been used to resolve
structural variants associated with Mendelian disease (48).
Long-read sequencing technologies are rapidly moving to-
wards the mainstay of high resolution HLA typing for transplant
registries in certain regions (37); with high resolution typing po-
tentially having implications for better matching, and clinical
outcomes of patients undergoing transplantation. This is even
more important in populations which are poorly represented in
current reference sequence databases, limiting disambiguation
of clinical types when using standard methods for typing. The
HLA diversity in Africa project, which aims to characterize high
resolution HLA types across >20 ethno-linguistic in Africa has
recently completed sequencing of 2000 individuals using long-
read sequencing, identifying high levels of novelty in class I and
class II HLA types (49). This panel will provide an important re-
source for clinical HLA typing in populations of African ances-
try, as well as a platform for highly accurate imputation of HLA
types in medical genetics research.
Using long-range PCR amplicons, with barcoding and long-
read technology also allow better delineation of genes from
pseudogenes, such as for sequencing PKD1 for diagnosing
autosomal-dominant polycystic kidney disease, for which diag-
nostic accuracy of NGS technologies has been limited (50).
SMRT sequencing has also been used to tailor treatment in
patients with cancer, by identifying low frequency resistant
mutations in BCR-ABL1 that affect treatment efficacy in patients
with CML (51). Applications of SMRT sequencing in reproductive
medicine, to identify parent of origin effects, and for pre-
implantation diagnosis have been previously noted (52).
Full sequencing of several virus genomes in a single contig
by long-read sequencing has provided unique avenues for iden-
tification of resistant mutations for clinical applications. Proof-
of concept studies have generated protocols to examine low
frequency (up to 0.25%) associated mutations for HIV and HCV
resistance to drugs, through deep sequencing of full length qua-
sispecies (53). Methylation profiles of pathogens examined us-
ing SMRT approaches have also been shown to correlate with
pathogenicity, and virulence, potentially providing a new ave-
nue for applications in infectious disease surveillance.
The Future
Long-read technologies are improving rapidly, and may become
the mainstay of sequencing; however, the broader application
of long-read technologies are currently limited by a lower
throughput, higher error rate and higher cost per base relative
to short read sequencing. Wider use of such technologies in the
clinical context may rapidly improve our understanding of can-
cer, pathogen evolution, drug resistance and genetic diversity in
complex regions of the genome that have important implica-
tions for clinical care. Parallel development of existing technol-
ogy to allow high throughput PCR-free sequencing will be
important in sequencing difficult regions of the genome (54).
At present, no single long-read technology has any clear ad-
vantage from a scientific point of view, and thus it seems likely
that the future of long-read sequencing is more likely to be de-
cided on commercial terms rather than scientific. Whichever
technology captures the market, it is clear that as these technol-
ogies become more affordable they will continue to shine a light
into previously intractable regions of the genome with ever
larger sample sizes and longer read-lengths, allowing new dis-
covery in these evolving fields.
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